•Kommersant reported that a little-known Russian company asked President Putin to place the Russian assets of Swiss group Nestle under temporary administration.
•AstraZeneca announced it is discontinuing a late-stage trial testing volrustomig plus chemotherapy in patients with metastatic non-small cell lung cancer.
•The first bellwether trial against Reckitt Benckiser subsidiary Mead Johnson began today in the US District Court for the Northern District of Illinois.
•The litigation involves allegations that Enfamil infant formula is linked to necrotizing enterocolitis (NEC) in premature infants.
•James Hardie is facing a shareholder class action in the Supreme Court of Victoria alleging misleading representations regarding its FY26 earnings guidance.
